BridgeMD
Compares treatment options for Gambling Disorder
Official title Internet-based Versus Synchronous Cognitive Behavioural Therapy for Patients With Gambling Disorder
ClinicalTrials.gov ID: NCT06989125
What this study is testing
- What it's testing
- The aim of this two-armed, randomized controlled trial is to determine if internet-based cognitive behavioural therapy (CBT) is as effective as synchronous CBT (sCBT) for treating Gambling Disorder (GD) in adults. The main question it aims to answer is: Is the effect of the internet-based CBT ("SpilleFri") non-inferior to that of synchronous CBT in reducing gambling severity?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- To be included patients should:
- fulfil diagnostic criteria for GD (DSM-5).
- score 4 points or more on the National Opinion Research Centre Screen for Gambling Problems (NODS).
- be able to read, write, and speak Danish.
- have IT skills and access to the internet and a computer, smartphone, and/or tablet.
You likely can't join if
- Patients are excluded from participation if they:
- present with severe comorbid somatic disease, cognitive deficits, severe trauma, and/or psychiatric disorder (e.g. depression, bipolar disorder...
- are not willing to engage in internet-delivered treatment or face-to-face cognitive behavioural therapy.
- do not provide informed consent.
- are in risk of suicide (indicated by clear intent and/or plans).
- have previously received treatment via or had access to the SpilleFri platform.
See the full eligibility criteria
- To be included patients should:
- fulfil diagnostic criteria for GD (DSM-5).
- score 4 points or more on the National Opinion Research Centre Screen for Gambling Problems (NODS).
- be able to read, write, and speak Danish.
- have IT skills and access to the internet and a computer, smartphone, and/or tablet.
- Patients are excluded from participation if they:
- present with severe comorbid somatic disease, cognitive deficits, severe trauma, and/or psychiatric disorder (e.g. depression, bipolar disorder, substance abuse, ADHD) that is insufficiently treated at the time of...
- are not willing to engage in internet-delivered treatment or face-to-face cognitive behavioural therapy.
- do not provide informed consent.
- are in risk of suicide (indicated by clear intent and/or plans).
- have previously received treatment via or had access to the SpilleFri platform.
- seek treatment as part of an imminent legal case.
- only fulfil diagnostic criteria for Gambling Disorder in relation to behaviour such as stock trading or buying and selling cryptocurrency.
- present with highly unstable social circumstances, which are considered to potentially pose a barrier to engaging in treatment (e.g., homelessness).
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Denmark, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Denmark, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.